The Good, the Bad and the Ugly of Scaling a Spin-off MedTech Company

Emilio is a serial entrepreneur with a successful track record bringing transformative technology solutions to market. His last start-up, Acurable, is particularly relevant to ETH. Acurable was a class II medical device spin-off from Imperial College London. He partnered with a professor behind a 10 years cutting-edge research project, and he took the company through all the stages from fundraising, clinical trials and regulatory approvals, to the launch in Europe and the US, and commercial scale. He will share key insights from the eight years he dedicated to building this company.